SAPL announcements Sanofi-Aventis Pakistan Limited
Sanofi-Aventis Pakistan Limited (SAPL) has 100 notices stored from the exchange, from 08 Jun 2020 to 30 Oct 2023. The newest is dated 30 Oct 2023; the titles below are the exchange’s own words.
Every notice stored, newest first
| Date | Kind | Title as filed | |
|---|---|---|---|
| 30 Oct 2023 | Report sent to shareholders | Transmission of Financial Statements for the Nine-Months Period Ended September 30, 2023 | |
| 23 Oct 2023 | Financial results | Financial Results for the Period Ended September 30, 2023 | |
| 13 Oct 2023 | Board meeting | BOARD MEETING AND ANNOUNCEMENT OF CLOSED PERIOD | |
| 02 Oct 2023 | Restructuring | Approval of Change of Name | |
| 28 Sep 2023 | Management change | APPOINTMENT OF DIRECTOR | |
| 05 Sep 2023 | Shareholding disclosure | Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations | — |
| 05 Sep 2023 | General meeting | CERTIFIED TRUE COPY OF THE RESOLUTIONS PASSED IN THE EXTRAORDINARY GENERAL MEETING OF SANOFI-AVENTIS PAKISTAN LIMITED U/C 5.6.9(b) OF THE PSX RULE BOOK | |
| 29 Aug 2023 | Report sent to shareholders | Transmission of Financial Statements for the Half Year Ended June 30, 2023 | |
| 29 Aug 2023 | General meeting | PUBLICATION OF NOTICE OF BALLOT PAPER UNDER REGULATION 8 OF THE COMPANIES (POSTAL BALLOT) REGULATIONS, 2018 | |
| 28 Aug 2023 | General meeting | Notice of Ballot Paper for Voting Through Post (Pre-Publication) | |
| 25 Aug 2023 | Financial results | Financial Results for the Half Year Ended June 30, 2023 | |
| 17 Aug 2023 | Board meeting | BOARD MEETING AND ANNOUNCEMENT OF CLOSED PERIOD | |
| 16 Aug 2023 | General meeting | Notice of Extraordinary General Meeting | |
| 15 Aug 2023 | General meeting | Notice of Extraordinary General Meeting (Pre-Publication) | |
| 09 Aug 2023 | General meeting | Information about Date and Time for Holding the Extraordinary General Meeting | |
| 09 Aug 2023 | Material information | Disclosure of Material Information | |
| 01 Aug 2023 | Book closure | BOARD MEETING AND ANNOUNCEMENT OF BOOK CLOSURE | |
| 27 Jul 2023 | Shareholding disclosure | Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations | — |
| 26 Jul 2023 | Shareholding disclosure | Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations REVOKED | — |
| 13 Jun 2023 | Management change | Appointment of Chief Executive Officer | |
| 12 Jun 2023 | Shareholding disclosure | Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations | — |
| 07 Jun 2023 | Corporate briefing | SAPL | Sanofi-Aventis Pakistan Limited Corporate Briefing Session - Presentation | |
| 05 Jun 2023 | Shareholding disclosure | Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations | — |
| 02 Jun 2023 | Corporate briefing | CORPORATE BRIEFING SESSION | |
| 02 Jun 2023 | Shareholding disclosure | Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations | — |
| 31 May 2023 | Report sent to shareholders | Transmission of Quarterly Report for the Period Ended March 31, 2023 | |
| 30 May 2023 | Financial results | Financial Results for the Period Ended March 31, 2023 | |
| 26 May 2023 | Management change | APPOINTMENT OF CHAIRMAN & CHIEF EXECUTIVE OFFICER | — |
| 25 May 2023 | General meeting | CERTIFIED TRUE COPY OF THE RESOLUTIONS PASSED IN THE ANNUAL GENERAL MEETING OF SANOFI-AVENTIS PAKISTAN LIMITED U/C 5.6.9 (b) OF THE PSX RULE BOOK | |
| 23 May 2023 | Board meeting | BOARD MEETING FOR THE PERIOD ENDED MARCH 31, 2023 | |
| 18 May 2023 | Regulatory notice | PUBLICATION OF NOTICE UNDER SECTION 159(4) OF THE COMPANIES ACT, 2017 AND BALLOT PAPER UNDER REGULATION 8 OF THE COMPANIES (POSTAL BALLOT) REGULATIONS, 2018 | |
| 17 May 2023 | General meeting | Notice of Ballot Paper for Voting Through Post (Pre-Publication) | |
| 17 May 2023 | General meeting | Notice of Election of Directors (Pre-Publication) | |
| 03 May 2023 | Shareholding disclosure | Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations | — |
| 03 May 2023 | Shareholding disclosure | Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations | — |
| 03 May 2023 | Report sent to shareholders | Transmission of Annual Report for the Year Ended 2022-12-31 | |
| 03 May 2023 | General meeting | Notice of Annual General Meeting | |
| 02 May 2023 | General meeting | Notice of Annual General Meeting (Pre-Publication) | |
| 02 May 2023 | Management change | CHANGE OF DIRECTORS | |
| 28 Apr 2023 | Material information | Disclosure of Material Information | |
| 28 Apr 2023 | Management change | RESIGNATION OF DIRECTOR | |
| 20 Apr 2023 | Financial results | Financial Results for the Year Ended December 31, 2022 | |
| 19 Apr 2023 | Board meeting | Board Meeting In Progress | |
| 12 Apr 2023 | Board meeting | Board Meeting for the year ended December 31, 2022 | |
| 04 Apr 2023 | Regulatory notice | Approval of Extension in Time for Holding the Annual General Meeting | |
| 29 Mar 2023 | Regulatory notice | Applied for Extension for Holding the AGM for the Year Ended December 31, 2022 | |
| 28 Oct 2022 | Report sent to shareholders | Transmission of Financial Statements for the period ended September 30, 2022 | |
| 27 Oct 2022 | Management change | Change of Company Secretary | |
| 27 Oct 2022 | Financial results | Financial Results for the Period Ended September 30, 2022 | |
| 19 Oct 2022 | Board meeting | Board Meeting for the period ended September 30, 2022 | |
| 11 Oct 2022 | General meeting | CERTIFIED TRUE COPY OF THE RESOLUTIONS PASSED IN THE EXTRA-ORDINARY GENERAL MEETING OF SANOFI-AVENTIS PAKISTAN LIMITED U/C 5.6.9 (b) OF THE PSX RULE BOOK | |
| 16 Sep 2022 | General meeting | Notice of Extraordinary General Meeting | |
| 15 Sep 2022 | General meeting | Notice of Extraordinary General Meeting (Pre-Publication) | |
| 31 Aug 2022 | Report sent to shareholders | Transmission of Financial Statements for the half-year ended June 30, 2022 | |
| 25 Aug 2022 | Financial results | Financial results for the half year ended June 30, 2022 | |
| 17 Aug 2022 | Board meeting | Board Meeting for the half year ended June 30, 2022 | |
| 16 Aug 2022 | Material information | Disclosure of Material information | |
| 21 Jul 2022 | Book closure | Notice of Book Closure | |
| 29 Jun 2022 | Material information | Material Information | |
| 06 May 2022 | Dividend or bonus payment | Credit of Final Cash Dividend for the Year 2021 | |
| 06 May 2022 | Material information | Material Information | |
| 06 May 2022 | Report sent to shareholders | Transmission of Quarterly Accounts for the Period Ended March 31, 2022 | |
| 28 Apr 2022 | Material information | Material Information | |
| 28 Apr 2022 | Financial results | Financial Results for the Quarter Ended March 31, 2022 | |
| 25 Apr 2022 | General meeting | Certified Extract of Resolutions passed at 54th Annual General Meeting | |
| 19 Apr 2022 | Board meeting | Board Meeting for the Quarter ended March 31, 2022 | |
| 04 Apr 2022 | General meeting | Notice of Annual General Meeting for the Year Ended December 31, 2021 | |
| 01 Apr 2022 | Report sent to shareholders | Transmission of Annual Report for the Year Ended December 31, 2021 | |
| 25 Mar 2022 | Financial results | Financial Results for the Year Ended December 31, 2021 | |
| 17 Mar 2022 | Board meeting | Board Meeting for the Year ended December 31, 2021 | |
| 30 Dec 2021 | Material information | Material Information | |
| 28 Dec 2021 | Material information | Material Information REVOKED | |
| 20 Dec 2021 | Material information | Material Information | |
| 22 Nov 2021 | Management change | Change of Company Secretary | — |
| 28 Oct 2021 | Report sent to shareholders | Transmission of Financial Statements for Period Ended September 30, 2021 | |
| 27 Oct 2021 | Financial results | Financial Results for the Period Ended September 30, 2021 | |
| 14 Oct 2021 | Board meeting | Board Meeting for the Period Ended September 30, 2021 | |
| 27 Aug 2021 | Announcement | SAPL Sanofi-Aventis Pakistan Limited - Half year ended June 30, 2021 Financial Statements | |
| 26 Aug 2021 | Financial results | Financial Results for the Six Months Ended June 30, 2021 | |
| 17 Aug 2021 | Board meeting | Board Meeting | |
| 05 May 2021 | Dividend or bonus payment | Credit of Final Cash Dividend for the Year 2020 | |
| 30 Apr 2021 | Report sent to shareholders | SAPL | Sanofi-Aventis Pakistan Limited - Transmission of Quarterly Report for the period ended March 31, 2021 | |
| 30 Apr 2021 | Report sent to shareholders | Transmission of Quarterly Accounts for the Period Ended March 31, 2021 | |
| 28 Apr 2021 | Financial results | Financial Results for the Quarter Ended March 31, 2021 | |
| 23 Apr 2021 | General meeting | Certified Extract of Resolutions passed at 53rd Annual General Meeting | |
| 19 Apr 2021 | Board meeting | Board Meeting for the Quarter ended March 31, 2021 | |
| 30 Mar 2021 | Report sent to shareholders | Transmission of Annual Report for the Year Ended December 31, 2020 | |
| 30 Mar 2021 | General meeting | Notice of Annual General Meeting for the Year Ended December 31, 2020 | |
| 02 Mar 2021 | Financial results | Financial Results for the Year Ended December 31, 2020 | |
| 18 Feb 2021 | Board meeting | Board Meeting for the Year ended December 31, 2020 | |
| 29 Oct 2020 | Report sent to shareholders | Transmission of Financial Statements for Period Ended September 30, 2020 | |
| 29 Oct 2020 | Report sent to shareholders | Transmission of Financial Statements for Period Ended September 30, 2019 REVOKED | |
| 27 Oct 2020 | Financial results | Financial Results for the Period Ended September 30, 2020 | |
| 16 Oct 2020 | Board meeting | Board Meeting for the Period Ended September 30, 2020 | |
| 13 Oct 2020 | Corporate briefing | Corporate Briefing Session for the year 2020 | |
| 28 Aug 2020 | Announcement | SAPL | Sanofi-Aventis Pakistan Limited - Half year ended June 30, 2020 Financial Statements | | |
| 26 Aug 2020 | Financial results | Financial Results for the Six Months Ended June 30, 2020 | |
| 17 Aug 2020 | Board meeting | BOARD MEETING FOR THE HALF YEAR ENDED JUNE 30, 2020 | |
| 17 Aug 2020 | Shareholding disclosure | Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations | |
| 08 Jun 2020 | Dividend or bonus payment | Credit of Final Cash Dividend for the Year 2019 |
Titles are the exchange’s own words. The kind is set by SuperX’s classifier. Source: the exchange (dps.psx.com.pk), read 16 Nov 2026.
By kind
- General meeting: 18
- Board meeting: 15
- Financial results: 14
- Report sent to shareholders: 14
- Material information: 9
- Shareholding disclosure: 9
- Management change: 7
- Corporate briefing: 3
- Dividend or bonus payment: 3
- Regulatory notice: 3
- Announcement: 2
- Book closure: 2
- Restructuring: 1
Counted from the 100 notices above. The kind is set by SuperX’s classifier. Source: the exchange (dps.psx.com.pk), read 16 Nov 2026.
More on SAPL
- SAPL share price and overview
- Pharmaceuticals sector
- SEARL announcements · The Searle Company Limited
- WYETH announcements · Wyeth Pakistan Limited
- ABOT announcements · Abbott Laboratories (Pakistan) Limited
- GLAXO announcements · GlaxoSmithKline Pakistan Limited
- HALEON announcements · Haleon Pakistan Limited
- HINOON announcements · Highnoon Laboratories Limited
Data from PSX via SuperX, delayed and provided for information only — not investment advice. Figures may contain errors; verify with your broker before acting. As of .